These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26216406)

  • 41. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
    Natarajan C; Bright JJ
    Genes Immun; 2002 Apr; 3(2):59-70. PubMed ID: 11960303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiR-30a Positively Regulates the Inflammatory Response of Microglia in Experimental Autoimmune Encephalomyelitis.
    Fang X; Sun D; Wang Z; Yu Z; Liu W; Pu Y; Wang D; Huang A; Liu M; Xiang Z; He C; Cao L
    Neurosci Bull; 2017 Dec; 33(6):603-615. PubMed ID: 28717866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells.
    Liu G; Guo J; Liu J; Wang Z; Liang D
    Clin Immunol; 2014 Oct; 154(2):127-40. PubMed ID: 25076485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains.
    Chung IY; Norris JG; Benveniste EN
    J Exp Med; 1991 Apr; 173(4):801-11. PubMed ID: 1901078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis.
    Liu JQ; Carl JW; Joshi PS; RayChaudhury A; Pu XA; Shi FD; Bai XF
    J Immunol; 2007 May; 178(10):6227-35. PubMed ID: 17475850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
    Wen J; Ribeiro R; Tanaka M; Zhang Y
    Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.
    Kang Z; Altuntas CZ; Gulen MF; Liu C; Giltiay N; Qin H; Liu L; Qian W; Ransohoff RM; Bergmann C; Stohlman S; Tuohy VK; Li X
    Immunity; 2010 Mar; 32(3):414-25. PubMed ID: 20303295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
    J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway.
    Lalive PH; Paglinawan R; Biollaz G; Kappos EA; Leone DP; Malipiero U; Relvas JB; Moransard M; Suter T; Fontana A
    Eur J Immunol; 2005 Mar; 35(3):727-37. PubMed ID: 15724248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
    Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of FXR pathway does not alter glial cell function.
    Albrecht S; Fleck AK; Kirchberg I; Hucke S; Liebmann M; Klotz L; Kuhlmann T
    J Neuroinflammation; 2017 Mar; 14(1):66. PubMed ID: 28351411
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
    Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
    Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain.
    Donninelli G; Saraf-Sinik I; Mazziotti V; Capone A; Grasso MG; Battistini L; Reynolds R; Magliozzi R; Volpe E
    J Neuroinflammation; 2020 May; 17(1):149. PubMed ID: 32375811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-1 promotes autoimmune neuroinflammation by suppressing endothelial heme oxygenase-1 at the blood-brain barrier.
    Hauptmann J; Johann L; Marini F; Kitic M; Colombo E; Mufazalov IA; Krueger M; Karram K; Moos S; Wanke F; Kurschus FC; Klein M; Cardoso S; Strauß J; Bolisetty S; Lühder F; Schwaninger M; Binder H; Bechman I; Bopp T; Agarwal A; Soares MP; Regen T; Waisman A
    Acta Neuropathol; 2020 Oct; 140(4):549-567. PubMed ID: 32651669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-17A and Multiple Sclerosis: Signaling Pathways, Producing Cells and Target Cells in the Central Nervous System.
    Kolbinger F; Huppertz C; Mir A; Padova FD
    Curr Drug Targets; 2016; 17(16):1882-1893. PubMed ID: 26953244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation.
    Boghozian R; McKenzie BA; Saito LB; Mehta N; Branton WG; Lu J; Baker GB; Noorbakhsh F; Power C
    Glia; 2017 Oct; 65(10):1590-1606. PubMed ID: 28707358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactions between hemopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain.
    Murphy CA; Hoek RM; Wiekowski MT; Lira SA; Sedgwick JD
    J Immunol; 2002 Dec; 169(12):7054-62. PubMed ID: 12471141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages.
    Ashbaugh JJ; Brambilla R; Karmally SA; Cabello C; Malek TR; Bethea JR
    J Immunol; 2013 May; 190(9):4525-34. PubMed ID: 23530149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.